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Comparison of Percutaneous Versus Open Repair of
Femoral Arteries During Aortic Endovascular Aortic
Repair
Nicolas Louis, Pascal Desgranges, Eric Allaire, Hicham
Kobeiter, Jean Marzelle, Jean-piere Becquemin. Val de
Marne, Hopital Henri Mondor, Creteil, France
Objectives: Purpose: to compare the safety of percuta-
neous access (PA) to open repair (OR) of the femoral artery
during endovascular aortic repair (EVAR and TEVAR).
Methods: Methods: A prospective nonrandomized
study was performed between January 2006 andNovember
2009. Parameters of patients who underwent endovascular
aortic repairs with either open femoral repair or percutane-
ous closure system (Preclose-proglide or Prostar tech-
nique) were collected in a dedicated database. Each patient
underwent CT angiography preoperatively and postopera-
tively at 1 and 12 months. Patient’ variables (Age, gender,
subcutaneous tissue depth, femoral artery diameter, type of
calcifications, type of closure device, and size of sheath)
were compared by using Chi-square, Fisher exact test, and
paired and independent samples t tests when appropriate.
Results: Results: Among 405 patients who underwent
endovascular aortic repair, we performed 185 OR (EVAR-
160, TEVAR-25) and 220 PA (EVAR-206, TEVAR-14).
Immediate conversion from PA to OR was necessary in 34
patients (15.6%), and was significantly more frequent in pa-
tients with a femoral artery diameter10mm (76.5% vs 4.6%;
p  0.006). No significant difference was observed between
the 2 groups regarding the length of in-hospital stay, the rate
of postoperative infections and of late complications (7.4% in
the PA group vs 4.3% in the OR group). The type of closure
device, the size of the sheath did not significantly influence the
outcome. However, late complications in PA group only
occurred on the side of the larger sheath.
Conclusions: Conclusions: In our study, PA carries a
higher risk of complications thanOR. PA is a safe technique
in patients with a femoral artery diameter  10 mm (4.6%
immediate conversion) but it did not decrease the length of
stay nor the postoperative complication rate.
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In Vivo Displacement Force (DF) Is Higher in Patients
Who Experience Aortic Endograft Migration: A 3D
Computational Analysis
Carlos A. Figueroa1, Victoria Yeh1, Charles A. Taylor1,
Madhu L. Gorrepati2, Christopher K. Zarins2. 1Bioengi-
neering, Stanford University, Stanford, CA; 2Stanford
School of Medicine, Stanford, CAObjectives: Current aortic endografts are designed to
resist downstream displacement. Nonetheless, migration
may occur during long-term follow-up due to the pulsatile
action of blood flow. We performed patient-specific com-
putational analysis of the 3D displacement forces (DF)
acting on abdominal endografts implanted in 16 patients.
Methods: We have developed computational fluid dy-
namics (CFD) techniques to quantitate the DF acting on
aortic endografts. Patient-specific computational models
were constructed in 16 patients using early (30day) post-
EVAR cardiac-gated CT and phase-contrast magnetic res-
onance imaging scans. Late migration occurred in 7 pa-
tients (each required secondary intervention at 1-8 years)
and 9 patients had no migration documented with follow-up
imaging for 5-10 years.
Results: Migration patients were similar in age and
comorbidities, but had larger aneurysms than non-migra-
tion patients (65.1  12.4 mm vs 49.8  6.5 mm). DF
varied in orientation and magnitude for each patient and
was greatly influenced by aneurysm and iliac angulation and
tortuosity as well as the individual patient hemodynamic
state. Themagnitude of DF for all patients was 4.03 1.85
Newtons (N), range 2.05N - 9.51N. The magnitude of DF
for migration patients (5.08  2.24 N) was significantly
greater than in non-migration patients (3.22 0.98N, p
0.05). The orientation of DF was primarily perpendicular
to the greatest curvature of the endograft, rather than in the
downstream direction of blood flow.
Conclusions: Pulsatile DF acting on aortic endografts
is significantly greater in magnitude in patients who expe-
rience late endograft migration. Late endograft migration
may be the result of continuous long-term exposure to
sideways oriented DF together with aneurysm size, curva-
ture and tortuosity considered in balance with the fixation
forces of the endograft. Calculation of postoperative en-
dograft DF may be a useful factor to understand the likeli-
hood of endograft migration.
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Outcomes of Carotid Artery Stenting Versus Historical
Surgical Controls in Patients With Radiation-Induced
Carotid Stenosis, With or Without Prior Neck Dissec-
tion
Tiziano Tallarita1, Gustavo S. Oderich1, Giuseppe Lan-
zino2, Joseph J. Ricotta1, Harry Cloft3, Thomas C. Bow-
er1, Fredric Meyer2, Audra A. Duncan1, Manju Kalra1,
Robert Brown4, Peter Gloviczki1. 1Division of Vascular
and Endovascular Surgery, Mayo Clinic, Rochester, MN;
2Mayo Clinic Neurosurgery, Rochester, MN; 3Mayo Clinic
Neuroradiology, Rochester, MN; 4Mayo Clinic Neurol-
ogy, Rochester, MN
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June Supplement 201094S AbstractsObjectives: To evaluate the outcomes of carotid artery
stenting (CAS) vs historical open surgery (OS) controls in
patients with radiation-induced carotid stenosis (RICS),
with or without prior radical neck dissection (RND).
Methods: We retrospectively reviewed 55 patients
treated for 68 RICS from a group of 5, 824 patients who had
carotid interventions from 1992-2009. Twenty-six patients
(29 arteries) were treated with CAS and 29 patients (39
arteries) with OS. CAS was performed using embolic protec-
tion as part of a prospective registry since 2003, after which
only 3 patients had OS for RICS. Patients were analyzed
according to their RND status ( or) for the end-points of
mortality, stroke/TIA, cranial nerve injury, wound complica-
tion, restenosis (50%) and reintervention.
Results:Clinical and anatomical characteristics were sim-
ilar between groups. There were no early deaths. At 30-days,
OSwas associatedwith stroke/TIA in1patient (2.5%), cranial
nerve injury in 3 (8%), and wound complications in 7 (18%),
with mean length of stay (LOS) of 16  33 days. Wound
complicationsweremore common inRNDpatients (36% vs
6%, p  0.01). In the CAS group, 2 patients (7%) had
stroke/TIA at 30-days, but none had cranial nerve injury or
wound complication, with mean LOS was 3  4 days (p 
0.01). Median follow-up was 26 months. OS was associated
with higher freedom from stroke/TIA at 3-years (100% vs
86  9%) and lower rates of restenosis (7% vs 32%) and
reintervention (0% vs 18%) than CAS (p 0.05). The higher
rate of restenosis and reintervention for CAS was observed
among both RND (33% and 17% vs 0% and 0%) and RND-
patients (25% and 25 % vs 10% and 0%).
Conclusions: CAS for RICS had shorter LOS, no
cranial nerve injury or wound complication, and similar
early stroke rate as compared to OS. However, the higher
rates of late neurologic events, restenosis and reinterven-
tion during follow-up may offset the early benefits of CAS
in patients who are candidates for OS.
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Changing Trends in Assessment and Management of
Carotid Body Tumors: A 35-Year Experience
Efthimios D. Avgerinos1, Elias Brountzos2, Andreas M.
Lazaris1, Anastasios Papapetrou1, Nikolas Ptohis2, Tri-
antafilos Giannakopoulos1, Christos Liapis1. 1Department
of Vascular Surgery, Attikon University Hospital, Athens
Medical School, Chaidari, Athens, Greece; 22nd Depart-
ment of Radiology, Attikon University Hospital, Athens
Medical School, Chaidari, Athens, GreeceObjectives: Conventional and modern functional im-
aging techniques, genetic screening and evolving surgical/
endovascular techniques accompanied (or not) with radio-
therapy and/or chemotherapy have altered the overall
management of carotid body tumors (CBT).We review our
35-year experience, emphasizing on the changing trends in
the evaluation and treatment of CBT.
Methods: Medical records of 27 patients diagnosed
with a CBT between 1975 and 2009 were retrospectively
reviewed.
Results: Our study cohort consisted of 8 Shamblin I,
10 II, and 9 III (3 with intracranial spread) tumors. During
the early years (18 cases up to 1998) CT-scanning and
angiography were used for diagnosis, while surgical exci-
sion following selective embolization, when indicated, was
standard care. Local lymph node invasion established the
diagnosis of malignancy in two patients. One of these
patients developed distal metastases 3 years later. After
2000 (9 cases), patients were co-evaluated by DOTA-
octreotide andMR imaging (3D TOFMRA), while also by
genetic screening when necessary. Among those, two sis-
ters with CBT and free parental history were assessed and
operated. A missense mutation Y114C, in exon-4 of the
SDHD gene, in the unaffected father and both affected
sisters was identified. Four other patients with large CBT
were pretreated via a covered stent placement in the “tumor
supplying” external carotid artery. One of these patients
required further neo-adjuvant chemotherapy which per-
mitted successful tumor resection.
Conclusions: Improved understanding of the patho-
physiology of CBT along with contemporary imaging,
surgical techniques and radio- chemotherapies have vastly
improved outcomes for patients. Surgeon and institutional
competence are critical in achieving maximal outcomes.
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Learning Curve Associated With the Use of the Carotid
Flow Reversal System
Karthikeshwar Kasirajan1, Daniel Clair2. 1Emory, Atlanta,
GA; 2Cleveland Clinic, Cleveland, OH
Objectives: Flow reversal for cerebral protection dur-
ing carotid angioplasty and stenting introduces a variety of
new imaging concepts and techniques that maybe associ-
ated with a significant learning curve to achieve optimal
outcomes. The aim of the study was to evaluate the learning
curve with the use of this new reverse flow technology.
Methods: Data were prospectively collected as part of
the EMPiRE study group evaluating the GORE Flow
Reversal System (WL Gore, Flagstaff, AZ) and divided into
4 groups. Group I (n  62) was the initial 2 training cases
